We demonstrated the mechanisms through which miR-93 inhibits PTEN and CDKN1A, thereby activating proliferation through the c-Met/PI3K/Akt pathway and inhibiting apoptosis in HCC. This evidence concerns the gene MET and hepatocellular carcinoma.